204 related articles for article (PubMed ID: 16380253)
1. Antiangiogenic activity of deoxoartemisinin derivatives on chorioallantoic membrane.
Jung M; Tak J; Chung WY; Park KK
Bioorg Med Chem Lett; 2006 Mar; 16(5):1227-30. PubMed ID: 16380253
[TBL] [Abstract][Full Text] [Related]
2. Synthesis and antiangiogenic activity of thioacetal artemisinin derivatives.
Oh S; Jeong IH; Ahn CM; Shin WS; Lee S
Bioorg Med Chem; 2004 Jul; 12(14):3783-90. PubMed ID: 15210144
[TBL] [Abstract][Full Text] [Related]
3. Synthesis and antiangiogenic activity of exo-olefinated deoxoartemisinin derivatives.
Oh S; Jeong IH; Shin WS; Lee S
Bioorg Med Chem Lett; 2004 Jul; 14(14):3683-6. PubMed ID: 15203143
[TBL] [Abstract][Full Text] [Related]
4. Antitumor activity of novel deoxoartemisinin monomers, dimers, and trimer.
Jung M; Lee S; Ham J; Lee K; Kim H; Kim SK
J Med Chem; 2003 Mar; 46(6):987-94. PubMed ID: 12620075
[TBL] [Abstract][Full Text] [Related]
5. Synthesis and anticancer activity of novel amide derivatives of non-acetal deoxoartemisinin.
Jung M; Park N; Moon HI; Lee Y; Chung WY; Park KK
Bioorg Med Chem Lett; 2009 Nov; 19(22):6303-6. PubMed ID: 19819696
[TBL] [Abstract][Full Text] [Related]
6. Synthesis of daumone derivatives and their antiangiogenic activities on chorioallantoic membrane.
Ricci J; Min D; Oh M; Lim H; Chung WY; Park KK; Jung M
Med Chem; 2015; 11(8):747-52. PubMed ID: 25974079
[TBL] [Abstract][Full Text] [Related]
7. Concise synthesis and antiangiogenic activity of artemisinin-glycolipid hybrids on chorioallantoic membranes.
Ricci J; Park J; Chung WY; Park KK; Jung M
Bioorg Med Chem Lett; 2010 Nov; 20(22):6858-60. PubMed ID: 20855209
[TBL] [Abstract][Full Text] [Related]
8. Semisynthesis and pharmacological activities of Tetrac analogs: angiogenesis modulators.
Bridoux A; Cui H; Dyskin E; Yalcin M; Mousa SA
Bioorg Med Chem Lett; 2009 Jun; 19(12):3259-63. PubMed ID: 19427201
[TBL] [Abstract][Full Text] [Related]
9. Facile synthesis and anticancer activity of C-10 non-acetal deoxoartemisinin dimers.
Phothongkam S; Chancharunee S; Saovapakhiran A; Wichai U; Pohmakotr M
Bioorg Med Chem Lett; 2012 Dec; 22(24):7598-601. PubMed ID: 23103096
[TBL] [Abstract][Full Text] [Related]
10. Antimalarial and antitumor evaluation of novel C-10 non-acetal dimers of 10beta-(2-hydroxyethyl)deoxoartemisinin.
Jeyadevan JP; Bray PG; Chadwick J; Mercer AE; Byrne A; Ward SA; Park BK; Williams DP; Cosstick R; Davies J; Higson AP; Irving E; Posner GH; O'Neill PM
J Med Chem; 2004 Feb; 47(5):1290-8. PubMed ID: 14971909
[TBL] [Abstract][Full Text] [Related]
11. Hydroxylation of 10-deoxoartemisinin by Cunninghamella elegans.
Parshikov IA; Muraleedharan KM; Miriyala B; Avery MA; Williamson JS
J Nat Prod; 2004 Sep; 67(9):1595-7. PubMed ID: 15387669
[TBL] [Abstract][Full Text] [Related]
12. Fumarranol, a rearranged fumagillin analogue that inhibits angiogenesis in vivo.
Lu J; Chong CR; Hu X; Liu JO
J Med Chem; 2006 Sep; 49(19):5645-8. PubMed ID: 16970390
[TBL] [Abstract][Full Text] [Related]
13. Synthesis of nοvel artemisinin dimers with polyamine linkers and evaluation of their potential as anticancer agents.
Magoulas GE; Tsigkou T; Skondra L; Lamprou M; Tsoukala P; Kokkinogouli V; Pantazaka E; Papaioannou D; Athanassopoulos CM; Papadimitriou E
Bioorg Med Chem; 2017 Jul; 25(14):3756-3767. PubMed ID: 28549888
[TBL] [Abstract][Full Text] [Related]
14. TX-2152: a conformationally rigid and electron-rich diyne analogue of FTY720 with in vivo antiangiogenic activity.
Nakayama S; Uto Y; Tanimoto K; Okuno Y; Sasaki Y; Nagasawa H; Nakata E; Arai K; Momose K; Fujita T; Hashimoto T; Okamoto Y; Asakawa Y; Goto S; Hori H
Bioorg Med Chem; 2008 Aug; 16(16):7705-14. PubMed ID: 18678496
[TBL] [Abstract][Full Text] [Related]
15. Synthesis and evaluation of graveoline and graveolinine derivatives with potent anti-angiogenesis activities.
An ZY; Yan YY; Peng D; Ou TM; Tan JH; Huang SL; An LK; Gu LQ; Huang ZS
Eur J Med Chem; 2010 Sep; 45(9):3895-903. PubMed ID: 20554355
[TBL] [Abstract][Full Text] [Related]
16. NMR studies on novel antitumor drug candidates, deoxoartemisinin and carboxypropyldeoxoartemisinin.
Lee CH; Hong H; Shin J; Jung M; Shin I; Yoon J; Lee W
Biochem Biophys Res Commun; 2000 Aug; 274(2):359-69. PubMed ID: 10913344
[TBL] [Abstract][Full Text] [Related]
17. 5'-O-tritylated nucleoside derivatives: inhibition of thymidine phosphorylase and angiogenesis.
Liekens S; Bronckaers A; Hernández AI; Priego EM; Casanova E; Camarasa MJ; Pérez-Pérez MJ; Balzarini J
Mol Pharmacol; 2006 Aug; 70(2):501-9. PubMed ID: 16675660
[TBL] [Abstract][Full Text] [Related]
18. Beta-elemene inhibits melanoma growth and metastasis via suppressing vascular endothelial growth factor-mediated angiogenesis.
Chen W; Lu Y; Wu J; Gao M; Wang A; Xu B
Cancer Chemother Pharmacol; 2011 Apr; 67(4):799-808. PubMed ID: 20563582
[TBL] [Abstract][Full Text] [Related]
19. Identification of campesterol from Chrysanthemum coronarium L. and its antiangiogenic activities.
Choi JM; Lee EO; Lee HJ; Kim KH; Ahn KS; Shim BS; Kim NI; Song MC; Baek NI; Kim SH
Phytother Res; 2007 Oct; 21(10):954-9. PubMed ID: 17604370
[TBL] [Abstract][Full Text] [Related]
20. Artesunate inhibits angiogenesis and downregulates vascular endothelial growth factor expression in chronic myeloid leukemia K562 cells.
Zhou HJ; Wang WQ; Wu GD; Lee J; Li A
Vascul Pharmacol; 2007; 47(2-3):131-8. PubMed ID: 17581794
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
